Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 8.6B | 7.8B | 8.8B | 9.0B |
Cost of revenue | 7.7B | 6.9B | 8.7B | 7.8B |
Gross profit | 916M | 965M | 154M | 1.2B |
Operating expense | ||||
Research & development | 62M | 55M | 76M | 62M |
Selling general and admin | 1.1B | 962M | 1.1B | 1.1B |
Other operating expenses | — | 46M | 29M | 32M |
Operating income | -205M | -98M | -1.0B | 13M |
Non operating interest income | ||||
Income | 170M | 258M | -385M | 182M |
Expense | 162M | 278M | -342M | 193M |
Other income expense | — | — | — | — |
Pretax income | 267M | 20M | -983M | 26M |
Tax provision | 101M | 53M | 57M | 59M |
Net income | 167M | -33M | -1.0B | -33M |
Basic EPS | 0.3 | -0.1 | — | -0.1 |
Diluted EPS | 0.3 | -0.1 | — | -0.1 |
Basic average shares | 622.5M | 622.5M | — | 622.5M |
Diluted average shares | 622.5M | 622.5M | — | 622.5M |
EBITDA | 708M | 590M | -234M | 391M |
Net income from continuing op. | 167M | -33M | -1.0B | -33M |
Minority interests | -11M | -18M | -21M | -21M |
Preferred stock dividends | 0 | 0 | 0 | 0 |